Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
about
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.Women and Ischemic Heart Disease: Recognition, Diagnosis and ManagementRanolazine: A Contemporary ReviewA randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveNew treatment options for late Na current, arrhythmias, and diastolic dysfunctionCurrent medical management of chronic stable anginaA double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndromeEffects of Ranolazine on Astrocytes and Neurons in Primary CultureComparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectorisManagement standards for stable coronary artery disease in India.Ranolazine recruits muscle microvasculature and enhances insulin action in rats.Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.Update on ranolazine in the management of angina.Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome.Nonacute coronary syndrome anginal chest pain.Cardiac Syndrome X: update 2014.Emerging clinical role of ranolazine in the management of angina.A rare debilitating neurological adverse effect of ranolazine due to drug interaction with clarithromycinEfficacy and safety of ranolazine in patients with chronic stable angina.Ranolazine: a new approach to treating an old problem.Switching from nitrate therapy to ranolazine in patients with coronary artery disease receiving phosphodiesterase type-5 inhibitors for erectile dysfunctionRanolazine: ion-channel-blocking actions and in vivo electrophysiological effects.Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium currentMechanism of action of the new anti-ischemia drug ranolazine.Treatment of refractory anginaComparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease - a randomized controlled trial.Anti-anginal and anti-ischemic effects of late sodium current inhibitionExtended-release ranolazine: critical evaluation of its use in stable angina.Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 DiabetesRanolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.Ischemic heart disease: metabolic approaches to management.Effect of late sodium current inhibition on MRI measured diastolic dysfunction in aortic stenosis: a pilot study.Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.Medical management of myocardial ischemia.Ranolazine: new approach for the treatment of stable angina pectoris.Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR.Metabolic modulators for chronic cardiac ischemia.Evolving treatment strategies for chronic refractory angina.Ranolazine, a novel agent for chronic stable angina.
P2860
Q24605881-21A0AC72-C63F-452A-B89C-59E96C53C961Q26740081-98C5D7B8-606D-4E07-ADB5-F1CACDBC6647Q26765421-C9AEC4FD-0951-4902-BBC4-86563473CC4AQ26776330-7D3E94BC-ADD3-4B61-A7D7-428043382280Q27012532-9178C202-54AB-4A10-AC83-D067CAABAF6FQ28213164-784EB967-2D60-4581-B5F0-F27893C98859Q28481488-DCC72EFE-00CF-485A-9FCC-DCB64F3F2599Q28550579-F104B44D-425A-4071-AF52-5B4E2524EE08Q28706249-488CE9B5-D2B5-40CC-9973-15FA7E073E75Q30239853-CB369033-AB6A-4843-A655-B2B3813CC1B9Q30456763-EEE2A17D-2E54-49E3-A8E7-ABE00B971324Q33151781-ED68F2B7-99DB-43BB-8C64-AEB5A54646ACQ33831222-F71B0B07-E047-4C07-82EC-01B6B0B5E58DQ33872995-CDEA0364-D575-471A-894E-944FDBB1F5A1Q33878551-70F2260A-2ADE-4BAA-B19C-6EF905F776FFQ34007353-F532593F-F156-414F-9643-09AED6303136Q34235939-53BE9FFE-E2D3-4FB2-9762-E39F24EEEC1EQ34247689-ABC3C7D0-0420-4EEB-B873-4E438385F43BQ34383219-AF9E2E8D-4DEA-4ADC-AAAC-FD2A6E8D7C78Q34457675-85564820-631B-44AC-9B3A-B55C07FA37F3Q34547499-01463A96-FA9C-48C7-82D5-4ACA85CCB333Q34549619-FCC5898A-B4E2-4EC8-BCDC-00FB8B6D4258Q34573997-2191B788-7133-439C-960E-2367F54FE9E0Q34693729-DC56C70C-1B45-4935-A715-1E0A8C3A1FF6Q34901966-C5D1815B-09D2-4F72-AD4A-F7C06640584FQ34986448-197B1DF7-38EE-4FD2-8C4A-E5E9E68C93C0Q35139678-97B23B2B-A1DE-4531-8B22-DABC88A2A895Q35147202-4120FEB6-282C-40B9-A92B-F84ACFB48D65Q35193935-0A3E0CE1-467A-4FED-AFB4-D4FD91460D0EQ35769527-CD09678B-07DB-4858-AFCB-2CC35108CE9EQ35873307-041B57BE-2308-4E29-81E2-61CB9C7F154AQ35878082-6AEC8DE8-6BEE-4A0D-BE58-1CA904E63D72Q35915087-13D64BC3-DDD8-44D8-AA3E-8D20EDC3F118Q35948315-F68B39C8-4481-407E-B129-463D9945E32DQ36193249-F7487334-5D7F-4583-AA11-DD70FC019968Q36266000-0EB13B17-96BF-4EF3-BA7A-1529E27DA559Q36288856-7352C299-D76A-41A0-8A7C-0720C024AC66Q36355273-C15FE148-813A-4978-8D24-8CFCEA037AD5Q36382563-70AA0B43-B47D-4A36-9FC4-282EB41407BEQ36408751-137BE7FA-086E-4010-AF98-A3A71F648CF7
P2860
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Anti-ischemic effects and long ...... ts with chronic severe angina.
@ast
Anti-ischemic effects and long ...... ts with chronic severe angina.
@en
Anti-ischemic effects and long ...... ts with chronic severe angina.
@nl
type
label
Anti-ischemic effects and long ...... ts with chronic severe angina.
@ast
Anti-ischemic effects and long ...... ts with chronic severe angina.
@en
Anti-ischemic effects and long ...... ts with chronic severe angina.
@nl
prefLabel
Anti-ischemic effects and long ...... ts with chronic severe angina.
@ast
Anti-ischemic effects and long ...... ts with chronic severe angina.
@en
Anti-ischemic effects and long ...... ts with chronic severe angina.
@nl
P2093
P1476
Anti-ischemic effects and long ...... ts with chronic severe angina.
@en
P2093
Andrew A Wolff
Bernard R Chaitman
Carl J Pepine
David A Hebert
Jaroslav Meluzin
Jeanenne J Nelson
Jerzy Kuch
John O Parker
MARISA Investigators
Peter Hanley
P304
P356
10.1016/J.JACC.2003.11.045
P407
P577
2004-04-01T00:00:00Z